Sen. Collins, Rep. Eshoo Decry Medicare Coverage Rejection of Alzheimer's Drugs
yahoo.com
finance
2022-10-18 19:12:00

'It's not CMS' job to deny the use under the Medicare program of an FDA-approved drug.' – Sen. Susan Collins; '…breakthroughs have to reach people, otherwise it really doesn't mean a darn thing to them.' – Rep. Anna Eshoo

Washington, D.C., Oct. 18, 2022 (GLOBE NEWSWIRE) -- During UsAgainstAlzheimer's 2022 National Summit, members of Congress, scientists, and other leaders spoke out against the Centers for Medicare and Medicaid Services (CMS) decision to deny Medicare coverage of FDA-approved Alzheimer's treatments.
